R
Robert Kohberger
Researcher at Pfizer
Publications - 24
Citations - 7193
Robert Kohberger is an academic researcher from Pfizer. The author has contributed to research in topics: Conjugate vaccine & Pneumococcal conjugate vaccine. The author has an hindex of 19, co-authored 24 publications receiving 7011 citations. Previous affiliations of Robert Kohberger include University of Pennsylvania & York University.
Papers
More filters
Journal ArticleDOI
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
Steven Black,Henry R. Shinefield,Bruce Fireman,Edwin Lewis,Paula Ray,John Hansen,Laura Elvin,Kathy M. Ensor,Jill G. Hackell,George R. Siber,Frank J. Malinoski,Dace V. Madore,Ih Chang,Robert Kohberger,Wendy J. Watson,Robert Austrian,Kathy Edwards +16 more
TL;DR: The Wyeth Lederle as discussed by the authors determined the efficacy, safety and immunogenicity of the CRM197 pneumococcal conjugate vaccine against invasive disease caused by vaccine serotypes and to determine the effectiveness of this vaccine against clinical episodes of otitis media.
Journal ArticleDOI
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Juhani Eskola,Terhi Kilpi,Arto A. Palmu,Jukka Jokinen,Haapakoski J,Herva E,A K Takala,Helena Käyhty,Pekka Karma,Robert Kohberger,George R. Siber,Mäkelä Ph +11 more
TL;DR: The heptavalent pneumococcal polysaccharide-CRM197 conjugate vaccine is safe and efficacious in the prevention of acute otitis media caused by the serotypes included in the vaccine.
Journal ArticleDOI
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
Keith P. Klugman,Keith P. Klugman,Shabir A. Madhi,Robin E. Huebner,Robert Kohberger,Nontombi Marylucy Mbelle,Nathaniel F. Pierce +6 more
TL;DR: Vaccination with a 9-valent pneumococcal conjugate vaccine reduced the incidence of radiologically confirmed pneumonia among children with and those without HIV infection.
Journal ArticleDOI
Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial
Katherine L. O'Brien,Lawrence H. Moulton,Raymond Reid,Robert Weatherholtz,Jane Oski,Laura H Brown,Gaurav Kumar,Alan J. Parkinson,Diana Hu,Jill G. Hackell,Ih Chang,Robert Kohberger,George R. Siber,Mathuram Santosham +13 more
TL;DR: PnCRM7 vaccine prevents vaccine serotype invasive pneumococcal disease even in a high risk population and other regions with similar disease burden should consider including this vaccine in the routine childhood vaccine schedule.
Journal ArticleDOI
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
Luis Jódar,Jay C. Butler,George M. Carlone,Ron Dagan,David Goldblatt,Helena Käyhty,Keith P. Klugman,Brian D. Plikaytis,George R. Siber,Robert Kohberger,Ih Chang,Thomas Cherian +11 more
TL;DR: This report analyses the various options with their relative merits and drawbacks and provides preliminary recommendations as guidance to regulatory agencies in evaluating these vaccines for the purposes of licensure.